🔎 Trials Near Me

መነሻ › Sickle Cell በሽታ › Texas

በTexas ለSickle Cell በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለSickle Cell በሽታ የሚደረጉ 11 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Texas Childrens Cancer and Hematology Center, Houston
  • U of TX Health Science Ct, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ12 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Texas Children's Hospital_Houston, Houston
  • UT Health University of Texas, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 2 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • UT Health University of Texas, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • UT Health Science Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ12 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06546670

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Blood and Cancer Center of Central Texas, Austin
  • North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
  • North Texas Comprehensive Hemophilia Treatment Center, Dallas
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT04398628

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • Baylor College of Medicine- Site Number : 8400055, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ10 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06975865

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Texas Children's Hopsital (NT-DMT), Houston
  • Texas Children's Hospital (MRD-HCT), Houston
  • UT San Antonio (NT-DMT), San Antonio
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ3 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT06941389

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

  • Site # 8400004, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT07247188

Sickle Cell Kidney Biorepository

  • Parkland Memorial Hospital, Dallas
  • University of Texas Southwestern Medical Center, Dallas
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT07064174

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Baylor College of Medicine, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ15 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT06260891

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Texas at Houston, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2025 · NCT06385886

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።